866-997-4948(US-Canada Toll Free)

Global Valsartan Drug Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Nov 2018

Category :

Pharmaceutical

No. of Pages : 125 Pages

Valsartan (trade name Diovan, Novartis International AG) is mainly used for treatment of high blood pressure, congestive heart failure, and to increase the chances of living longer after a heart attack. It is an angiotensin II receptor antagonist (commonly called an ARB, or angiotensin receptor blocker), that is selective for the type I (AT1) angiotensin receptor.
In 2017, the global Valsartan Drug market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Valsartan Drug market based on company, product type, application and key regions.

This report studies the global market size of Valsartan Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Valsartan Drug in these regions.
This research report categorizes the global Valsartan Drug market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

The various contributors involved in the value chain of Valsartan Drug include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Valsartan Drug include
Novartis
Sun Pharmaceutical
Teva
Mylan
Alembic Pharmaceuticals
Lupin
Aurobindo Pharma
Macleods Pharmaceuticals
HETERO
Torrent Pharmaceuticals
Huaren Pharmaceutical
Jubilant Pharma
Amneal Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Square Pharmaceuticals
Unichem Laboratories

Market Size Split by Type
40 mg Tablets
80 mg Tablets
160 mg Tablets
320 mg Tablets
Market Size Split by Application
Hypertension
Heart Failure
Heart Attack

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Valsartan Drug market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Valsartan Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Valsartan Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Valsartan Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Valsartan Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Valsartan Drug are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Valsartan Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Valsartan Drug Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Valsartan Drug Market Size Growth Rate by Type
1.4.2 40 mg Tablets
1.4.3 80 mg Tablets
1.4.4 160 mg Tablets
1.4.5 320 mg Tablets
1.5 Market by Application
1.5.1 Global Valsartan Drug Market Size Growth Rate by Application
1.5.2 Hypertension
1.5.3 Heart Failure
1.5.4 Heart Attack
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Valsartan Drug Market Size
2.1.1 Global Valsartan Drug Revenue 2016-2025
2.1.2 Global Valsartan Drug Sales 2016-2025
2.2 Valsartan Drug Growth Rate by Regions
2.2.1 Global Valsartan Drug Sales by Regions
2.2.2 Global Valsartan Drug Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Valsartan Drug Sales by Manufacturers
3.1.1 Valsartan Drug Sales by Manufacturers
3.1.2 Valsartan Drug Sales Market Share by Manufacturers
3.1.3 Global Valsartan Drug Market Concentration Ratio (CR5 and HHI)
3.2 Valsartan Drug Revenue by Manufacturers
3.2.1 Valsartan Drug Revenue by Manufacturers (2016-2018)
3.2.2 Valsartan Drug Revenue Share by Manufacturers (2016-2018)
3.3 Valsartan Drug Price by Manufacturers
3.4 Valsartan Drug Manufacturing Base Distribution, Product Types
3.4.1 Valsartan Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Valsartan Drug Product Category
3.4.3 Date of International Manufacturers Enter into Valsartan Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Valsartan Drug Sales by Type
4.2 Global Valsartan Drug Revenue by Type
4.3 Valsartan Drug Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Valsartan Drug Breakdown Data by Application

6 North America
6.1 North America Valsartan Drug by Countries
6.1.1 North America Valsartan Drug Sales by Countries
6.1.2 North America Valsartan Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Valsartan Drug by Type
6.3 North America Valsartan Drug by Application
6.4 North America Valsartan Drug by Company

7 Europe
7.1 Europe Valsartan Drug by Countries
7.1.1 Europe Valsartan Drug Sales by Countries
7.1.2 Europe Valsartan Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Valsartan Drug by Type
7.3 Europe Valsartan Drug by Application
7.4 Europe Valsartan Drug by Company

8 Asia Pacific
8.1 Asia Pacific Valsartan Drug by Countries
8.1.1 Asia Pacific Valsartan Drug Sales by Countries
8.1.2 Asia Pacific Valsartan Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Valsartan Drug by Type
8.3 Asia Pacific Valsartan Drug by Application
8.4 Asia Pacific Valsartan Drug by Company

9 Central & South America
9.1 Central & South America Valsartan Drug by Countries
9.1.1 Central & South America Valsartan Drug Sales by Countries
9.1.2 Central & South America Valsartan Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Valsartan Drug by Type
9.3 Central & South America Valsartan Drug by Application
9.4 Central & South America Valsartan Drug by Company

10 Middle East and Africa
10.1 Middle East and Africa Valsartan Drug by Countries
10.1.1 Middle East and Africa Valsartan Drug Sales by Countries
10.1.2 Middle East and Africa Valsartan Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Valsartan Drug by Type
10.3 Middle East and Africa Valsartan Drug by Application
10.4 Middle East and Africa Valsartan Drug by Company

11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Valsartan Drug
11.1.4 Valsartan Drug Product Description
11.1.5 Recent Development
11.2 Sun Pharmaceutical
11.2.1 Sun Pharmaceutical Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Valsartan Drug
11.2.4 Valsartan Drug Product Description
11.2.5 Recent Development
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Valsartan Drug
11.3.4 Valsartan Drug Product Description
11.3.5 Recent Development
11.4 Mylan
11.4.1 Mylan Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Valsartan Drug
11.4.4 Valsartan Drug Product Description
11.4.5 Recent Development
11.5 Alembic Pharmaceuticals
11.5.1 Alembic Pharmaceuticals Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Valsartan Drug
11.5.4 Valsartan Drug Product Description
11.5.5 Recent Development
11.6 Lupin
11.6.1 Lupin Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Valsartan Drug
11.6.4 Valsartan Drug Product Description
11.6.5 Recent Development
11.7 Aurobindo Pharma
11.7.1 Aurobindo Pharma Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Valsartan Drug
11.7.4 Valsartan Drug Product Description
11.7.5 Recent Development
11.8 Macleods Pharmaceuticals
11.8.1 Macleods Pharmaceuticals Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Valsartan Drug
11.8.4 Valsartan Drug Product Description
11.8.5 Recent Development
11.9 HETERO
11.9.1 HETERO Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Valsartan Drug
11.9.4 Valsartan Drug Product Description
11.9.5 Recent Development
11.10 Torrent Pharmaceuticals
11.10.1 Torrent Pharmaceuticals Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Valsartan Drug
11.10.4 Valsartan Drug Product Description
11.10.5 Recent Development
11.11 Huaren Pharmaceutical
11.12 Jubilant Pharma
11.13 Amneal Pharmaceuticals
11.14 Zhejiang Huahai Pharmaceutical
11.15 Square Pharmaceuticals
11.16 Unichem Laboratories

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Valsartan Drug Raw Material
13.1.2 Valsartan Drug Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Valsartan Drug
Figure Global Valsartan Drug Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Valsartan Drug Production Market Share by Types (Product Category) in 2017
Figure 40 mg Tablets Product Picture
Table Major Manufacturers of 40 mg Tablets
Figure 80 mg Tablets Product Picture
Table Major Manufacturers of 80 mg Tablets
Figure 160 mg Tablets Product Picture
Table Major Manufacturers of 160 mg Tablets
Figure 320 mg Tablets Product Picture
Table Major Manufacturers of 320 mg Tablets
Table Global Valsartan Drug Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Hypertension
Figure Heart Failure
Figure Heart Attack
Figure Valsartan Drug Report Years Considered
Figure Global Valsartan Drug Market Size 2016-2025 (Million US$)
Figure Global Valsartan Drug Sales 2016-2025 (K Units)
Table Global Valsartan Drug Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Valsartan Drug Sales by Regions 2016-2025 (K Units)
Table Global Valsartan Drug Sales Market Share by Regions 2016-2025
Figure Global Valsartan Drug Sales Market Share by Regions 2016-2025
Figure 2017 Global Valsartan Drug Sales Market Share by Regions
Table Global Valsartan Drug Revenue by Regions 2016-2025 (Million US$)
Table Global Valsartan Drug Revenue Market Share by Regions 2016-2025
Figure Global Valsartan Drug Revenue Market Share by Regions 2016-2025
Figure 2017 Global Valsartan Drug Revenue Market Share by Regions
Table Global Valsartan Drug Sales by Manufacturers (2016-2018) (K Units)
Table Global Valsartan Drug Sales Share by Manufacturers (2016-2018)
Figure Global Valsartan Drug Sales Share by Manufacturers in 2017
Table Valsartan Drug Revenue by Manufacturers (2016-2018) (Million US$)
Table Valsartan Drug Revenue Share by Manufacturers (2016-2018)
Figure Valsartan Drug Value Share by Manufacturers in 2017
Table Global Valsartan Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Valsartan Drug Price (2016-2018) (USD/Unit)
Table Valsartan Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Valsartan Drug Product Category
Table Date of International Manufacturers Enter into Valsartan Drug Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Valsartan Drug Sales by Type (2016-2025) (K Units)
Table Global Valsartan Drug Sales Share by Type (2016-2025)
Figure Global Valsartan Drug Sales Market Share by Type (2016-2025)
Figure Global Valsartan Drug Sales Market Share by Type in 2017
Table Global Valsartan Drug Revenue by Type (2016-2025) (Million US$)
Table Global Valsartan Drug Revenue Share by Type (2016-2025)
Figure Global Valsartan Drug Revenue Market Share by Type (2016-2025)
Figure Global Valsartan Drug Revenue Market Share by Type in 2017
Table Valsartan Drug Price by Type 2013-2018 (USD/Unit)
Table Global Valsartan Drug Sales by Application (2016-2025) (K Units)
Table Global Valsartan Drug Sales Share by Application (2016-2025)
Figure Global Sales Valsartan Drug Market Share by Application (2016-2025)
Figure Global Sales Valsartan Drug Market Share by Application (2016-2025)
Figure North America Valsartan Drug Sales Growth Rate 2016-2025 (K Units)
Figure North America Valsartan Drug Revenue Growth Rate 2016-2025 (Million US$)
Table North America Valsartan Drug Sales by Countries (2016-2025) (K Units)
Table North America Valsartan Drug Sales Market Share by Countries (2016-2025)
Figure 2017 North America Valsartan Drug Sales Market Share by Countries
Table North America Valsartan Drug Revenue by Countries (2016-2025) (Million US$)
Table North America Valsartan Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Valsartan Drug Revenue Market Share by Countries
Figure United States Valsartan Drug Sales Growth Rate (2016-2025) (K Units)
Figure United States Valsartan Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Valsartan Drug Sales Growth Rate (2016-2025) (K Units)
Figure Canada Valsartan Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Valsartan Drug Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Valsartan Drug Revenue Growth Rate (2016-2025) (Million US$)
Table North America Valsartan Drug Sales by Type (2016-2025) (K Units)
Table North America Valsartan Drug Sales Market Share by Type (2016-2025)
Figure 2017 North America Valsartan Drug Market Share by Type
Table North America Valsartan Drug Sales by Application (2016-2025) (K Units)
Table North America Valsartan Drug Sales Market Share by Application (2016-2025)
Figure 2017 North America Valsartan Drug Market Share by Application
Table North America Valsartan Drug Sales by Company (2016-2018) (K Units)
Table North America Valsartan Drug Sales Market Share by Company (2016-2018)
Figure North America Valsartan Drug Sales Market Share by Company in 2017
Figure Europe Valsartan Drug Sales Growth Rate 2016-2025 (K Units)
Figure Europe Valsartan Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Valsartan Drug Sales by Countries (2016-2025) (K Units)
Table Europe Valsartan Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Valsartan Drug Sales Market Share by Countries
Table Europe Valsartan Drug Revenue by Countries (2016-2025) (Million US$)
Table Europe Valsartan Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Valsartan Drug Revenue Market Share by Countries
Figure Germany Valsartan Drug Sales Growth Rate (2016-2025) (K Units)
Figure Germany Valsartan Drug Revenue Growth Rate (2016-2025) (K Units)
Figure France Valsartan Drug Sales Growth Rate (2016-2025) (K Units)
Figure France Valsartan Drug Revenue Growth Rate (2016-2025) (K Units)
Figure UK Valsartan Drug Sales Growth Rate (2016-2025) (K Units)
Figure UK Valsartan Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Valsartan Drug Sales Growth Rate (2016-2025) (K Units)
Figure Italy Valsartan Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Valsartan Drug Sales Growth Rate (2016-2025) (K Units)
Figure Russia Valsartan Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Valsartan Drug Sales by Type (2016-2025) (K Units)
Table Europe Valsartan Drug Sales Market Share by Type (2016-2025)
Figure 2017 Europe Valsartan Drug Market Share by Type
Table Europe Valsartan Drug Sales by Application (2016-2025) (K Units)
Table Europe Valsartan Drug Sales Market Share by Application (2016-2025)
Figure 2017 Europe Valsartan Drug Market Share by Application
Table Europe Valsartan Drug Sales by Company (2016-2018) (K Units)
Table Europe Valsartan Drug Sales Market Share by Company (2016-2018)
Figure Europe Valsartan Drug Sales Market Share by Company in 2017
Figure Asia Pacific Valsartan Drug Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Valsartan Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Valsartan Drug Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Valsartan Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Valsartan Drug Sales Market Share by Countries
Table Asia Pacific Valsartan Drug Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Valsartan Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Valsartan Drug Revenue Market Share by Countries
Figure China Valsartan Drug Sales Growth Rate (2016-2025) (K Units)
Figure China Valsartan Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Valsartan Drug Sales Growth Rate (2016-2025) (K Units)
Figure Japan Valsartan Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Valsartan Drug Sales Growth Rate (2016-2025) (K Units)
Figure Korea Valsartan Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure India Valsartan Drug Sales Growth Rate (2016-2025) (K Units)
Figure India Valsartan Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Valsartan Drug Sales Growth Rate (2016-2025) (K Units)
Figure Australia Valsartan Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Valsartan Drug Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Valsartan Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Valsartan Drug Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Valsartan Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Valsartan Drug Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Valsartan Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Valsartan Drug Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Valsartan Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Valsartan Drug Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Valsartan Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Valsartan Drug Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Valsartan Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Valsartan Drug Sales by Type (2016-2025) (K Units)
Table Asia Pacific Valsartan Drug Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Valsartan Drug Market Share by Type
Table Asia Pacific Valsartan Drug Sales by Application (2016-2025) (K Units)
Table Asia Pacific Valsartan Drug Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Valsartan Drug Market Share by Application
Table Asia Pacific Valsartan Drug Sales by Company (2016-2018) (K Units)
Table Asia Pacific Valsartan Drug Sales Market Share by Company (2016-2018)
Figure Asia Pacific Valsartan Drug Sales Market Share by Company in 2017
Figure Central & South America Valsartan Drug Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Valsartan Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Valsartan Drug Sales by Countries (2016-2025) (K Units)
Table Central & South America Valsartan Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Valsartan Drug Sales Market Share by Countries
Table Central & South America Valsartan Drug Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Valsartan Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Valsartan Drug Revenue Market Share by Countries
Figure Brazil Valsartan Drug Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Valsartan Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Valsartan Drug Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Valsartan Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Valsartan Drug Sales by Type (2016-2025) (K Units)
Table Central & South America Valsartan Drug Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Valsartan Drug Market Share by Type
Table Central & South America Valsartan Drug Sales by Application (2016-2025) (K Units)
Table Central & South America Valsartan Drug Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Valsartan Drug Market Share by Application
Table Central & South America Valsartan Drug Sales by Company (2016-2018) (K Units)
Table Central & South America Valsartan Drug Sales Market Share by Company (2016-2018)
Figure Central & South America Valsartan Drug Sales Market Share by Company in 2017
Figure Middle East and Africa Valsartan Drug Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Valsartan Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Valsartan Drug Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Valsartan Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Valsartan Drug Sales Market Share by Countries
Table Middle East and Africa Valsartan Drug Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Valsartan Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Valsartan Drug Revenue Market Share by Countries
Figure GCC Countries Valsartan Drug Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Valsartan Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Valsartan Drug Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Valsartan Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Valsartan Drug Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Valsartan Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Valsartan Drug Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Valsartan Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Valsartan Drug Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Valsartan Drug Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Valsartan Drug Market Share by Type
Table Middle East and Africa Valsartan Drug Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Valsartan Drug Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Valsartan Drug Market Share by Application
Table Middle East and Africa Valsartan Drug Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Valsartan Drug Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Valsartan Drug Sales Market Share by Company in 2017
Table Novartis Company Details
Table Novartis Valsartan Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Novartis Recent Development
Table Sun Pharmaceutical Company Details
Table Sun Pharmaceutical Valsartan Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sun Pharmaceutical Recent Development
Table Teva Company Details
Table Teva Valsartan Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Teva Recent Development
Table Mylan Company Details
Table Mylan Valsartan Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Mylan Recent Development
Table Alembic Pharmaceuticals Company Details
Table Alembic Pharmaceuticals Valsartan Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Alembic Pharmaceuticals Recent Development
Table Lupin Company Details
Table Lupin Valsartan Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Lupin Recent Development
Table Aurobindo Pharma Company Details
Table Aurobindo Pharma Valsartan Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Aurobindo Pharma Recent Development
Table Macleods Pharmaceuticals Company Details
Table Macleods Pharmaceuticals Valsartan Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Macleods Pharmaceuticals Recent Development
Table HETERO Company Details
Table HETERO Valsartan Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table HETERO Recent Development
Table Torrent Pharmaceuticals Company Details
Table Torrent Pharmaceuticals Valsartan Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Torrent Pharmaceuticals Recent Development
Table Huaren Pharmaceutical Company Details
Table Jubilant Pharma Company Details
Table Amneal Pharmaceuticals Company Details
Table Zhejiang Huahai Pharmaceutical Company Details
Table Square Pharmaceuticals Company Details
Table Unichem Laboratories Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Valsartan Drug Value Chain
Table Typical Suppliers of Key Valsartan Drug Raw Material
Table Valsartan Drug Customers List
Table Valsartan Drug Sales Channels
Table Valsartan Drug Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *